
OMERS Growth Equity
Description
OMERS Growth Equity is the growth equity investment arm of OMERS, one of Canada's largest defined benefit pension plans. Headquartered in Toronto, with additional offices in London and New York, the firm leverages the vast resources and global network of its parent organization, which manages over C$128 billion (approximately US$95 billion) in net assets as of December 31, 2023. The team is dedicated to partnering with high-growth companies that are disrupting their respective markets, primarily focusing on the technology and healthcare sectors.
The investment strategy of OMERS Growth Equity centers on providing significant minority or control investments to later-stage companies with proven business models, strong recurring revenue, and clear paths to market leadership. They seek out businesses that have already achieved substantial scale but require capital and strategic guidance to accelerate their global expansion, enhance product development, or pursue strategic acquisitions. Their approach is characterized by patient, long-term capital, reflecting their pension fund origins, which allows portfolio companies to focus on sustainable growth rather than short-term returns.
Typically, OMERS Growth Equity makes initial investments ranging from US$50 million to US$250 million. This substantial cheque size enables them to be a meaningful partner in significant growth rounds, often participating as lead investors or co-leads. Beyond capital, the firm offers operational expertise, access to a global network of industry experts, and support in areas such as talent acquisition, international market entry, and M&A strategy. Their commitment extends to helping portfolio companies navigate complex growth challenges and achieve their full potential on a global scale.
Investor Profile
OMERS Growth Equity has backed more than 20 startups, with 0 new investments in the last 12 months alone. The firm has led 12 rounds, about 60% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series C, Series E rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Artificial Intelligence (AI), SaaS.
- Typical check size: $50M – $250M.
Stage Focus
- Series D (35%)
- Series C (25%)
- Series E (20%)
- Series F (10%)
- Series B (5%)
- Private Equity (5%)
Country Focus
- United States (90%)
- Canada (10%)
Industry Focus
- Health Care
- Artificial Intelligence (Ai)
- Saas
- Analytics
- Software
- Insurtech
- Wellness
- Medical
- Primary And Urgent Care
- Machine Learning
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.